Answers are grounded in this paper and cite their sources.
This study examined whether redesigning glaucoma medication packaging improves perceived readability and product identification for adults with glaucoma. Glaucoma-related visual field loss and reduced contrast sensitivity impair reading, yet standard medication packaging often fails to accommodate these limitations, increasing the risk of confusion and medication errors. To address this, we redesigned four package designs of a widely used glaucoma medication (latanoprost), targeting typographic legibility, colour differentiation, and label clutter. Thirty-six patients with glaucoma evaluated a visualization of the original against the redesigned packages, rating ease of product identification and perceived readability. Participants preferred the redesigned over the original packaging for three of the four package designs on both outcomes, with no significant preference observed for one package design. These findings show that evidence-based packaging redesign can improve perceived readability and product identification for people with glaucoma, demonstrating how user-centred design can enhance accessibility and reduce medication errors.
No takes yet. Share an insight, caveat, or question.
Beier et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: